PTK2 and breast cancer: In our analyses, we found that breast cancer cells with FAK-copy-gain showed higher sensitivity to FAK inhibitor 14 (F14), a FAK inhibitor, which is known to inhibit cancer cell growth via its inhibition of FAK phosphorylation at Y397 [11].